The usefulness of chest CT imaging in patients with suspected or diagnosed COVID-19: a review of literature
S Machnicki, D Patel, A Singh, A Talwar, B Mina, M Oks… - Chest, 2021 - Elsevier
The COVID-19 pandemic has had devastating medical and economic consequences
globally. The severity of COVID-19 is related, in a large measure, to the extent of pulmonary …
globally. The severity of COVID-19 is related, in a large measure, to the extent of pulmonary …
Janus kinase signaling pathway and its role in COVID-19 inflammatory, vascular, and thrombotic manifestations
JD Ravid, O Leiva, VC Chitalia - Cells, 2022 - mdpi.com
Acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection continues to be a
worldwide public health crisis. Among the several severe manifestations of this disease …
worldwide public health crisis. Among the several severe manifestations of this disease …
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
Background The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been
equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation …
equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation …
Anticoagulant biomimetic consecutive gas exchange network for advanced artificial lung membrane
Y Feng, Q Wang, L Zhi, S Sun, C Zhao - Journal of Membrane Science, 2022 - Elsevier
Artificial lung membrane as extracorporeal blood-gas barriers could execute similar
functions as human alveoli, whereby accomplish blood gas exchange process, providing …
functions as human alveoli, whereby accomplish blood gas exchange process, providing …
Association between COVID-19 diagnosis and coronary artery thrombosis: a narrative review
F Nappi, O Giacinto, O Ellouze, A Nenna… - Biomedicines, 2022 - mdpi.com
Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …
[HTML][HTML] A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection
S Vahdat - IJC Heart & Vasculature, 2022 - Elsevier
Abstract Severe coronavirus (COVID-19) infection has been reportedly associated with a
high risk of thromboembolism. Developing macrovascular thrombotic complications …
high risk of thromboembolism. Developing macrovascular thrombotic complications …
COVID‐19 coagulopathies: Human blood proteins mimic SARS‐CoV‐2 virus, vaccine proteins and bacterial co‐infections inducing autoimmunity: Combinations of …
R Root‐Bernstein - Bioessays, 2021 - Wiley Online Library
Severe COVID‐19 is often accompanied by coagulopathies such as thrombocytopenia and
abnormal clotting. Rarely, such complications follow SARS‐CoV‐2 vaccination. The cause …
abnormal clotting. Rarely, such complications follow SARS‐CoV‐2 vaccination. The cause …
Mixed storm in SARS‐CoV‐2 infection: a narrative review and new term in the Covid‐19 era
BM Alomair, HM Al‐Kuraishy… - Immunity …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (Covid‐19) is caused by a novel severe acute
respiratory syndrome coronavirus virus type 2 (SARS‐CoV‐2) leading to the global …
respiratory syndrome coronavirus virus type 2 (SARS‐CoV‐2) leading to the global …
The SARS-coV-2/receptor axis in heart and blood vessels: A crisp update on COVID-19 disease with cardiovascular complications
P Veluswamy, M Wacker, D Stavridis, T Reichel… - Viruses, 2021 - mdpi.com
The SARS-CoV-2 virus causing COVID-19 disease has emerged expeditiously in the world
and has been declared pandemic since March 2020, by World Health Organization (WHO) …
and has been declared pandemic since March 2020, by World Health Organization (WHO) …
In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease
Y Cao, C Geng, Y Li, Y Zhang - Frontiers in Pharmacology, 2021 - frontiersin.org
Pulmonary thromboembolism (PTE) is the third leading cause of death in cardiovascular
diseases. PTE is believed to be caused by thrombi detached from deep veins of lower …
diseases. PTE is believed to be caused by thrombi detached from deep veins of lower …